Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA database | Synapse
March 3, 2026
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA database
Puntos clave
Irradiation and endocrine therapy affect outcomes in older breast cancer patients, promoting better management strategies.
In EUSOMA's dataset, patients aged 65 and older showed varied responses to treatment combinations, indicating personalized care needs.
Analysis of treatment pathways for luminal A-like, low-risk breast cancer highlights the complexity in clinical decision-making.
Findings may enable tailored therapeutic approaches for older patients, improving survival and quality of life.